Celentyx Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Celentyx Ltd - overview
Established
2004
Location
Birmingham, England, UK
Primary Industry
Pharmaceuticals
About
Celentyx Ltd is based in Birmingham, UK and is a pharmaceutical company that develops treatments for diseases of the human immune system.
Current Investors
Mercia Asset Management, Mercia Fund Management
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.celentyx.com
Total Amount Raised
Subscriber access only
Celentyx Ltd - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - |
| Operating Margin | - | - | - | - | - | - |
| % EBITDA Margin | - | - | - | - | - | - |
| NET Income (USD) | 119,997 | 87,850 | 111,733 | - | - | - |
| % Net Margin | - | - | - | - | - | - |
Celentyx Ltd - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Celentyx Ltd | - |
Displaying 1 - 1 of 1
Celentyx Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.